speb/financial-data huggingface dataset:
BSVN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 233027000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 233027000.00
BSVN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2268000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 218839000.00
BSVN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 40593000.00
BSVN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -71774000.00
BSVN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 9450000.00
BSVN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -2175000.00
BSVN cash_flow (quarterly, 2025-06-30) — Change In Payable: -2175000.00
BSVN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2175000.00
BSVN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -414000.00
BSVN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -2589000.00
BSVN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -414000.00
BSVN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -21731000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Common Stock: 94000.00
BSVN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2268000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 231859000.00
BSVN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 305000.00
BSVN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 305000.00
BSVN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 289000.00
BSVN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 289000.00
BSVN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 9545128.00
BSVN income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.16
BSVN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 11105000.00
BSVN cash_flow (quarterly, 2025-06-30) — End Cash Position: 218839000.00
BSVN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 40593000.00
BSVN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 8811000.00
BSVN cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
BSVN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3742000.00
BSVN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 5721000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Goodwill: 11208000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12023000.00
BSVN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 7239000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
BSVN income_statement (quarterly, 2025-06-30) — Interest Expense: 10043000.00
BSVN income_statement (quarterly, 2025-06-30) — Interest Income: 31781000.00
BSVN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 10048000.00
BSVN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -71774000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 58352000.00
BSVN cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
BSVN income_statement (quarterly, 2025-06-30) — Net Income: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 11105000.00
BSVN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Net Interest Income: 21738000.00
BSVN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 3306000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Net PPE: 21102000.00
BSVN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -639000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 219836000.00
BSVN income_statement (quarterly, 2025-06-30) — Normalized Income: 11105000.00
BSVN income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 991000.00
BSVN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 9450000.00
BSVN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -517000.00
BSVN income_statement (quarterly, 2025-06-30) — Operating Revenue: 24439000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 9449319.00
BSVN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3742000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 815000.00
BSVN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 44000.00
BSVN income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 2639000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 381000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 29753000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Payables: 0.00
BSVN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 0.00
BSVN income_statement (quarterly, 2025-06-30) — Pretax Income: 14707000.00
BSVN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1030000.00
BSVN income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 158000.00
BSVN cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
BSVN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
BSVN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -639000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Receivables: 381000.00
BSVN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 289000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 133186000.00
BSVN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 5721000.00
BSVN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 3306000.00
BSVN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
BSVN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 223000.00
BSVN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 5944000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Share Issued: 9449319.00
BSVN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 762000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 231859000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 219836000.00
BSVN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BSVN income_statement (quarterly, 2025-06-30) — Tax Provision: 3602000.00
BSVN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
BSVN balance_sheet (quarterly, 2025-06-30) — Total Assets: 1836346000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 231859000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1604487000.00
BSVN balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
BSVN income_statement (quarterly, 2025-09-30) — +Total Revenue: 25236000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 103184000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 26572000.00
BSVN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 9450984.00
BSVN income_statement (quarterly, 2025-09-30) — Basic EPS: 1.15
BSVN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 218839000.00
BSVN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -214000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 95000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 256703000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 256703000.00
BSVN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2268000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Cash Financial: 241768000.00
BSVN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 40443000.00
BSVN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -34143000.00
BSVN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 16629000.00
BSVN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2239000.00
BSVN cash_flow (quarterly, 2025-09-30) — Change In Payable: 2239000.00
BSVN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2239000.00
BSVN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1362000.00
BSVN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3601000.00
BSVN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1362000.00
BSVN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 22929000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Common Stock: 95000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 241736000.00
BSVN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 1000.00
BSVN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -359000.00
BSVN cash_flow (quarterly, 2025-09-30) — Deferred Tax: -359000.00
BSVN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 290000.00
BSVN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 290000.00
BSVN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 9597914.00
BSVN income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.13
BSVN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 10844000.00
BSVN cash_flow (quarterly, 2025-09-30) — End Cash Position: 241768000.00
BSVN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 40443000.00
BSVN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 16415000.00
BSVN cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
BSVN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -10000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3021000.00
BSVN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5829000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Goodwill: 11208000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 11992000.00
BSVN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 3180000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 146000.00
BSVN income_statement (quarterly, 2025-09-30) — Interest Expense: 10691000.00
BSVN income_statement (quarterly, 2025-09-30) — Interest Income: 33717000.00
BSVN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 10548000.00
BSVN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -34143000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 56027000.00
BSVN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 1000.00
BSVN cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
BSVN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 1000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Income: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 10844000.00
BSVN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Net Interest Income: 23026000.00
BSVN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 3210000.00
BSVN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -9000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Net PPE: 21057000.00
BSVN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -214000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 229744000.00
BSVN income_statement (quarterly, 2025-09-30) — Normalized Income: 10844000.00
BSVN income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 1010000.00
BSVN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 16629000.00
BSVN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -380000.00
BSVN income_statement (quarterly, 2025-09-30) — Operating Revenue: 25236000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 9451979.00
BSVN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -3021000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 784000.00
BSVN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1048000.00
BSVN income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 3078000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 29455000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Payables: 146000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 146000.00
BSVN income_statement (quarterly, 2025-09-30) — Pretax Income: 14186000.00
BSVN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 30000.00
BSVN income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 221000.00
BSVN cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
BSVN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
BSVN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -214000.00
BSVN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 290000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 141478000.00
BSVN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 5829000.00
BSVN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3210000.00
BSVN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
BSVN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 212000.00
BSVN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6041000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Share Issued: 9451979.00
BSVN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 842000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 241736000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 229744000.00
BSVN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BSVN income_statement (quarterly, 2025-09-30) — Tax Provision: 3342000.00
BSVN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
BSVN balance_sheet (quarterly, 2025-09-30) — Total Assets: 1891435000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 241736000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1649699000.00
BSVN balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 146000.00
BSVN income_statement (annual, 2025-12-31) — +Total Revenue: 96376000.00
BSVN income_statement (quarterly, 2025-12-31) — +Total Revenue: 24105000.00
BSVN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -8333000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -8333000.00
BSVN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 103739000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 103739000.00
BSVN balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 1165000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1165000.00
BSVN income_statement (annual, 2025-12-31) — Basic Average Shares: 9444105.00
BSVN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 9454366.00
BSVN income_statement (annual, 2025-12-31) — Basic EPS: 4.56
BSVN income_statement (quarterly, 2025-12-31) — Basic EPS: 1.14
BSVN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 234196000.00
BSVN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 241768000.00
BSVN cash_flow (annual, 2025-12-31) — Capital Expenditure: -4740000.00
BSVN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1084000.00
BSVN balance_sheet (annual, 2025-12-31) — Capital Stock: 95000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 95000.00
BSVN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 255092000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 255092000.00
BSVN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 255092000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 255092000.00
BSVN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -9342000.00
BSVN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2552000.00
BSVN balance_sheet (annual, 2025-12-31) — Cash Financial: 244635000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 244635000.00
BSVN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 174889000.00
BSVN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 61203000.00
BSVN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -210586000.00
BSVN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -67395000.00
BSVN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 46136000.00
BSVN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9059000.00
BSVN cash_flow (annual, 2025-12-31) — Change In Account Payable: 387000.00
BSVN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1063000.00
BSVN cash_flow (annual, 2025-12-31) — Change In Payable: 387000.00
BSVN cash_flow (quarterly, 2025-12-31) — Change In Payable: -1063000.00
BSVN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 387000.00
BSVN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1063000.00
BSVN cash_flow (annual, 2025-12-31) — Change In Receivables: 13000.00
BSVN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1238000.00
BSVN cash_flow (annual, 2025-12-31) — Change In Working Capital: 400000.00
BSVN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2301000.00
BSVN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 13000.00
BSVN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1238000.00
BSVN cash_flow (annual, 2025-12-31) — Changes In Cash: 10439000.00
BSVN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2867000.00
BSVN balance_sheet (annual, 2025-12-31) — Common Stock: 95000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Common Stock: 95000.00
BSVN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -9342000.00
BSVN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 250995000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 250995000.00
BSVN cash_flow (annual, 2025-12-31) — Deferred Income Tax: -344000.00
BSVN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -369000.00
BSVN cash_flow (annual, 2025-12-31) — Deferred Tax: -344000.00
BSVN cash_flow (quarterly, 2025-12-31) — Deferred Tax: -369000.00
BSVN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1119000.00
BSVN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 289000.00
BSVN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1119000.00
BSVN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 289000.00
BSVN income_statement (annual, 2025-12-31) — Diluted Average Shares: 9574190.00
BSVN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 9599897.00
BSVN income_statement (annual, 2025-12-31) — Diluted EPS: 4.50
BSVN income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.12
BSVN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 10784000.00
BSVN cash_flow (annual, 2025-12-31) — End Cash Position: 244635000.00
BSVN cash_flow (quarterly, 2025-12-31) — End Cash Position: 244635000.00
BSVN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 174889000.00
BSVN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 61203000.00
BSVN cash_flow (annual, 2025-12-31) — Free Cash Flow: 41396000.00
BSVN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 7975000.00
BSVN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 10000.00
BSVN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
BSVN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
BSVN cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
BSVN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -10000.00
BSVN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
BSVN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2546000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2546000.00
BSVN income_statement (annual, 2025-12-31) — General And Administrative Expense: 22634000.00
BSVN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5805000.00
BSVN balance_sheet (annual, 2025-12-31) — Goodwill: 11208000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Goodwill: 11208000.00
BSVN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 11960000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 11960000.00
BSVN balance_sheet (annual, 2025-12-31) — Gross PPE: 30217000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 30217000.00
BSVN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 13714000.00
BSVN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 3295000.00
BSVN balance_sheet (annual, 2025-12-31) — Income Tax Payable: 594000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 594000.00
BSVN income_statement (annual, 2025-12-31) — Interest Expense: 40885000.00
BSVN income_statement (quarterly, 2025-12-31) — Interest Expense: 10551000.00
BSVN income_statement (annual, 2025-12-31) — Interest Income: 128758000.00
BSVN income_statement (quarterly, 2025-12-31) — Interest Income: 32816000.00
BSVN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 40949000.00
BSVN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 10604000.00
BSVN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -210586000.00
BSVN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -67395000.00
BSVN balance_sheet (annual, 2025-12-31) — Investments And Advances: 37896000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 37896000.00
BSVN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3526000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3526000.00
BSVN cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -2750000.00
BSVN cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
BSVN income_statement (annual, 2025-12-31) — Net Income: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Income: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10784000.00
BSVN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 43069000.00
BSVN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Net Interest Income: 87873000.00
BSVN income_statement (quarterly, 2025-12-31) — Net Interest Income: 22265000.00
BSVN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 9041000.00
BSVN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 1415000.00
BSVN balance_sheet (annual, 2025-12-31) — Net PPE: 21884000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Net PPE: 21884000.00
BSVN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4740000.00
BSVN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1084000.00
BSVN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 239035000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 239035000.00
BSVN income_statement (annual, 2025-12-31) — Normalized Income: 43069000.00
BSVN income_statement (quarterly, 2025-12-31) — Normalized Income: 10784000.00
BSVN income_statement (annual, 2025-12-31) — Occupancy And Equipment: 3858000.00
BSVN income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 1014000.00
BSVN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 46136000.00
BSVN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 9059000.00
BSVN cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1316000.00
BSVN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -326000.00
BSVN income_statement (annual, 2025-12-31) — Operating Revenue: 96376000.00
BSVN income_statement (quarterly, 2025-12-31) — Operating Revenue: 24105000.00
BSVN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 9462656.00
BSVN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 9462656.00
BSVN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2546000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2546000.00
BSVN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 752000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 752000.00
BSVN cash_flow (annual, 2025-12-31) — Other Non Cash Items: -752000.00
BSVN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 131000.00
BSVN income_statement (annual, 2025-12-31) — Other Non Interest Expense: 10745000.00
BSVN income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 2567000.00
BSVN balance_sheet (annual, 2025-12-31) — Other Properties: 1091000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Other Properties: 1091000.00
BSVN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 36731000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 36731000.00
BSVN balance_sheet (annual, 2025-12-31) — Payables: 594000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Payables: 594000.00
BSVN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 594000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 594000.00
BSVN income_statement (annual, 2025-12-31) — Pretax Income: 56765000.00
BSVN income_statement (quarterly, 2025-12-31) — Pretax Income: 14158000.00
BSVN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -1131000.00
BSVN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -1276000.00
BSVN income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 757000.00
BSVN income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 273000.00
BSVN balance_sheet (annual, 2025-12-31) — Properties: 25600000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Properties: 25600000.00
BSVN cash_flow (annual, 2025-12-31) — Purchase Of Business: -2750000.00
BSVN cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
BSVN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -40000.00
BSVN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
BSVN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4740000.00
BSVN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1084000.00
BSVN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1119000.00
BSVN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 289000.00
BSVN balance_sheet (annual, 2025-12-31) — Retained Earnings: 149707000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 149707000.00
BSVN income_statement (annual, 2025-12-31) — Salaries And Wages: 22634000.00
BSVN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 5805000.00
BSVN cash_flow (annual, 2025-12-31) — Sale Of Investment: 9081000.00
BSVN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 1415000.00
BSVN cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
BSVN cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
BSVN income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 917000.00
BSVN income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 288000.00
BSVN income_statement (annual, 2025-12-31) — Selling General And Administration: 23551000.00
BSVN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6093000.00
BSVN balance_sheet (annual, 2025-12-31) — Share Issued: 9462656.00
BSVN balance_sheet (quarterly, 2025-12-31) — Share Issued: 9462656.00
BSVN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 3062000.00
BSVN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 806000.00
BSVN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 250995000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 250995000.00
BSVN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 239035000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 239035000.00
BSVN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BSVN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BSVN income_statement (annual, 2025-12-31) — Tax Provision: 13696000.00
BSVN income_statement (quarterly, 2025-12-31) — Tax Provision: 3374000.00
BSVN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
BSVN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
BSVN balance_sheet (annual, 2025-12-31) — Total Assets: 1963640000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Total Assets: 1963640000.00
BSVN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 250995000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 250995000.00
BSVN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1712645000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1712645000.00
BSVN balance_sheet (annual, 2025-12-31) — Total Tax Payable: 594000.00
BSVN balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 594000.00
BSVN income_statement (quarterly, 2026-03-31) — +Total Revenue: 26158000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 103270000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1158000.00
BSVN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 9491075.00
BSVN income_statement (quarterly, 2026-03-31) — Basic EPS: 1.26
BSVN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 244635000.00
BSVN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2490000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 95000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 250436000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 250436000.00
BSVN cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -2555000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Cash Financial: 246701000.00
BSVN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -33135000.00
BSVN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 18552000.00
BSVN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 16649000.00
BSVN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 2051000.00
BSVN cash_flow (quarterly, 2026-03-31) — Change In Payable: 2051000.00
BSVN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 2051000.00
BSVN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 2911000.00
BSVN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 4962000.00
BSVN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 2911000.00
BSVN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2066000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Common Stock: 95000.00
BSVN cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -2555000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 259821000.00
BSVN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 497000.00
BSVN cash_flow (quarterly, 2026-03-31) — Deferred Tax: 497000.00
BSVN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 290000.00
BSVN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 290000.00
BSVN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 9596869.00
BSVN income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.25
BSVN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 12006000.00
BSVN cash_flow (quarterly, 2026-03-31) — End Cash Position: 246701000.00
BSVN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -33135000.00
BSVN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 14159000.00
BSVN cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -17000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -2687000.00
BSVN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 6331000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Goodwill: 11208000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 11929000.00
BSVN cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
BSVN balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 3912000.00
BSVN income_statement (quarterly, 2026-03-31) — Interest Expense: 9591000.00
BSVN income_statement (quarterly, 2026-03-31) — Interest Income: 33783000.00
BSVN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 9555000.00
BSVN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 18552000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 36147000.00
BSVN cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
BSVN income_statement (quarterly, 2026-03-31) — Net Income: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 12006000.00
BSVN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Net Interest Income: 24192000.00
BSVN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 1651000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Net PPE: 24110000.00
BSVN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2468000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 247892000.00
BSVN income_statement (quarterly, 2026-03-31) — Normalized Income: 12006000.00
BSVN income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 1028000.00
BSVN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 16649000.00
BSVN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -392000.00
BSVN income_statement (quarterly, 2026-03-31) — Operating Revenue: 26158000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 9519335.00
BSVN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2687000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 721000.00
BSVN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1412000.00
BSVN income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 2221000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 34989000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Payables: 3912000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3912000.00
BSVN income_statement (quarterly, 2026-03-31) — Pretax Income: 15821000.00
BSVN cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -1128000.00
BSVN income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 585000.00
BSVN cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
BSVN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
BSVN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2490000.00
BSVN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 290000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 159143000.00
BSVN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 6331000.00
BSVN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 1651000.00
BSVN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 22000.00
BSVN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 172000.00
BSVN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 6503000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Share Issued: 9519335.00
BSVN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 659000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 259821000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 247892000.00
BSVN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BSVN income_statement (quarterly, 2026-03-31) — Tax Provision: 3815000.00
BSVN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
BSVN balance_sheet (quarterly, 2026-03-31) — Total Assets: 1945080000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 259821000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1685259000.00
BSVN balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 3912000.00
BSVN income_statement (quarterly, 2026-06-30) — Basic Average Shares: 9519335.00
BSVN income_statement (quarterly, 2026-06-30) — Basic EPS: 0.88
BSVN income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 9604143.00
BSVN income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.87
BSX income_statement (annual, 2021-12-31) — Amortization: 741000000.00
BSX balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
BSX cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -55000000.00
BSX cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
BSX cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
BSX balance_sheet (annual, 2021-12-31) — Current Provisions: 264000000.00
BSX balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 3000000.00
BSX balance_sheet (annual, 2021-12-31) — Financial Assets: 169000000.00
BSX balance_sheet (annual, 2021-12-31) — Foreign Currency Translation Adjustments: 93000000.00
BSX cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -78000000.00
BSX income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 78000000.00
BSX balance_sheet (annual, 2021-12-31) — Hedging Assets Current: 226000000.00
BSX income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 341000000.00
BSX balance_sheet (annual, 2021-12-31) — Investments And Advances: 412000000.00
BSX cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
BSX balance_sheet (annual, 2021-12-31) — Long Term Provisions: 284000000.00
BSX balance_sheet (annual, 2021-12-31) — Minimum Pension Liabilities: -36000000.00
BSX cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
BSX cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 27000000.00
BSX cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 15000000.00
BSX cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -1000000.00
BSX cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
BSX balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 197000000.00
BSX balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 276000000.00
BSX balance_sheet (annual, 2021-12-31) — Other Inventories: 1000000.00
BSX balance_sheet (annual, 2021-12-31) — Other Properties: 435000000.00
BSX income_statement (annual, 2021-12-31) — Other Special Charges: 430000000.00
BSX cash_flow (annual, 2021-12-31) — Preferred Stock Dividend Paid: -55000000.00
BSX income_statement (annual, 2021-12-31) — Preferred Stock Dividends: 55000000.00
BSX cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
BSX cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
BSX balance_sheet (annual, 2021-12-31) — Restricted Cash: 188000000.00
BSX cash_flow (annual, 2021-12-31) — Sale Of Business: 826000000.00
BSX cash_flow (annual, 2021-12-31) — Sale Of Intangibles: 361000000.00
BSX cash_flow (annual, 2021-12-31) — Sale Of Investment: 15000000.00
BSX cash_flow (annual, 2021-12-31) — Sale Of PPE: 14000000.00
BSX cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
BSX income_statement (annual, 2021-12-31) — Total Expenses: 10064000000.00
BSX balance_sheet (annual, 2021-12-31) — Total Tax Payable: 209000000.00
BSX balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 442000000.00
BSX balance_sheet (annual, 2021-12-31) — Work In Process: 128000000.00
BSX income_statement (annual, 2022-12-31) — +Operating Expense: 6693000000.00
BSX income_statement (annual, 2022-12-31) — +Total Revenue: 12682000000.00
BSX balance_sheet (annual, 2022-12-31) — Accounts Payable: 862000000.00
BSX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1970000000.00
BSX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3282000000.00
BSX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 20289000000.00
BSX balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -109000000.00
BSX income_statement (annual, 2022-12-31) — Amortization: 803000000.00
BSX cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 803000000.00
BSX cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 803000000.00
BSX income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 803000000.00
BSX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 132000000.00
BSX income_statement (annual, 2022-12-31) — Basic Average Shares: 1430500000.00
BSX income_statement (annual, 2022-12-31) — Basic EPS: 0.45
BSX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2168000000.00
BSX balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1695000000.00
BSX cash_flow (annual, 2022-12-31) — Capital Expenditure: -612000000.00
BSX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 352000000.00
BSX balance_sheet (annual, 2022-12-31) — Capital Stock: 17000000.00
BSX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 928000000.00
BSX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 928000000.00
BSX cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -55000000.00
BSX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -547000000.00
BSX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2011000000.00
BSX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1527000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Account Payable: -255000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Inventory: -321000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -209000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Payable: -255000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -255000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Receivables: -220000000.00
BSX cash_flow (annual, 2022-12-31) — Change In Working Capital: -1005000000.00
BSX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -220000000.00
BSX cash_flow (annual, 2022-12-31) — Changes In Cash: -1033000000.00
BSX balance_sheet (annual, 2022-12-31) — Common Stock: 17000000.00
BSX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 17574000000.00
BSX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
BSX cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
BSX balance_sheet (annual, 2022-12-31) — Construction In Progress: 598000000.00
BSX income_statement (annual, 2022-12-31) — Cost Of Revenue: 3956000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1930000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Assets: 5760000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Debt: 20000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 20000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 220000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 220000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Liabilities: 3803000000.00
BSX balance_sheet (annual, 2022-12-31) — Current Provisions: 231000000.00
BSX cash_flow (annual, 2022-12-31) — Deferred Income Tax: -63000000.00
BSX cash_flow (annual, 2022-12-31) — Deferred Tax: -63000000.00
BSX cash_flow (annual, 2022-12-31) — Depreciation: 333000000.00
BSX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1136000000.00
BSX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 803000000.00
BSX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1136000000.00
BSX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 803000000.00
BSX balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
BSX income_statement (annual, 2022-12-31) — Diluted Average Shares: 1439700000.00
BSX income_statement (annual, 2022-12-31) — Diluted EPS: 0.45
BSX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 642000000.00
BSX income_statement (annual, 2022-12-31) — EBIT: 1611000000.00
BSX income_statement (annual, 2022-12-31) — EBITDA: 2747000000.00
BSX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -9000000.00
BSX cash_flow (annual, 2022-12-31) — End Cash Position: 1126000000.00
BSX balance_sheet (annual, 2022-12-31) — Financial Assets: 149000000.00
BSX cash_flow (annual, 2022-12-31) — Financing Cash Flow: -548000000.00
BSX balance_sheet (annual, 2022-12-31) — Finished Goods: 1171000000.00
BSX cash_flow (annual, 2022-12-31) — Free Cash Flow: 914000000.00
BSX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1000000.00
BSX cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 22000000.00
BSX income_statement (annual, 2022-12-31) — Gain On Sale Of Business: -22000000.00